J. Michael Hamilton
Directeur Technique/Scientifique/R&D chez OTraces, Inc.
Profil
J.
Michael Hamilton is the Chief Medical Officer at OTraces, Inc. He previously held positions as Group Director-Oncology at GSK Plc from 2001 to 2006, Chief Medical Officer at Noble Life Sciences, Inc., and Chief Medical Officer at Avalon Pharmaceuticals, Inc. Prior to that, he was the Section Chief-Clinical Investigations at the National Cancer Institute from 1985 to 2001.
Hamilton holds a doctorate from George Washington University and an undergraduate degree from the University of Connecticut.
Postes actifs de J. Michael Hamilton
| Sociétés | Poste | Début |
|---|---|---|
OTraces, Inc.
 OTraces, Inc. Medical/Nursing ServicesHealth Services OTraces, Inc. provides transformative oncology diagnostic systems and services to detect cancer. It has developed a protein-based method (proteomics) for detecting cancers with simple blood tests. It offers CDx instrument system, OTraces reagenat test kits, BC sera Dx test kit, PR sera Dx test kit, and Pipeline. The company was founded by Keith Lingerfelter and Alain Cappeluti in 2008 and is headquartered in Sykesville, MD. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de J. Michael Hamilton
| Sociétés | Poste | Fin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/01/2006 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01/01/2001 |
Noble Life Sciences, Inc.
 Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Directeur Technique/Scientifique/R&D | - |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Directeur Technique/Scientifique/R&D | - |
Formation de J. Michael Hamilton
| George Washington University | Doctorate Degree |
| University of Connecticut | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GSK PLC | Health Technology |
| Entreprise privées | 4 |
|---|---|
OTraces, Inc.
OTraces, Inc. Medical/Nursing ServicesHealth Services OTraces, Inc. provides transformative oncology diagnostic systems and services to detect cancer. It has developed a protein-based method (proteomics) for detecting cancers with simple blood tests. It offers CDx instrument system, OTraces reagenat test kits, BC sera Dx test kit, PR sera Dx test kit, and Pipeline. The company was founded by Keith Lingerfelter and Alain Cappeluti in 2008 and is headquartered in Sykesville, MD. | Health Services |
Noble Life Sciences, Inc.
Noble Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Noble Life Sciences, Inc. provides in vitro and in vivo preclinical drug development services. It specializes in personalized medicine and biomarker research and preclinical drug development. The company was founded by Kenneth C. Carter in 2010 and is headquartered in Sykesville, MD. | Health Technology |
Avalon Pharmaceuticals, Inc.
Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |